Razumab 2.3mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Ranibizumab (2.3mg)
Overview Razumab 2.3mg Injection
Diabetic retinopathy, macular degeneration, and macular edema are treated with a 2.3mg injection of Razumab. This medication targets abnormal blood vessel growth and leakage within the eye, mitigating vision loss. Administered directly into the eye by an ophthalmologist, self-injection is strictly prohibited. Potential side effects include conjunctival bleeding, ocular pain, floaters, elevated intraocular pressure, and eye inflammation. Persistent side effects or any concerning symptoms warrant immediate medical attention. Driving is discouraged following injection due to potential visual impairment.
Primary Ingredients of Razumab 2.3mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Razumab 2.3mg Injection
Eye conditions associated with diabetes, age-related macular degeneration (wet type), and macular swelling from retinal vein blockage.
Major Benefits of Razumab 2.3mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Razumab 2.3mg Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Razumab 2.3mg Injection:
This medication will be administered by your physician or registered nurse; please refrain from self-medicating.
How Razumab 2.3mg Injection works:
Injected Razumab (2.3mg) is an anti-angiogenesis therapy. Its mechanism of action involves VEGF inhibition, thus preventing the formation and permeability of compromised ocular blood vessels, thereby mitigating vision impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Razumab 2.3mg Injection may pose unknown risks. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Razumab 2.3mg Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
The administration of Razumab 2.3mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Following administration of Razumab 2.3mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneySAFE IF PRESCRIBED
The use of Razumab 2.3mg Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate that dosage modification may be unnecessary for this population. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Razumab 2.3mg Injection in patients with liver disease appears to present a low risk. Available evidence indicates that dose modification may be unnecessary for this patient population. However, physician consultation is recommended.
What if you forget to take Razumab 2.3mg Injection :
Should you forget a dose of the Razumab 2.3mg Injection, seek advice from your physician.
Facts to Know About Razumab 2.3mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Actions | Anti-VEGF therapy for age-related macular degeneration |
3,018 People bought this recently